The difference in median eGFR between the two groups did not reach statistical significance (p = 0.478) and was not aggravated over 1 year, as illustrated in Fig. 2 .
← all excerpts
A comparative analysis of clinical outcomes between conversion to mTOR inhibitor and calcineurin inhibitor reduction in managing BK viremia among kidney transplant patients.
1
0.4780
0.4780